Medical Industry News | Cardiology

Editor's Choice

Stem cell perfusion promotes repair
after heart attack, improves outcome

Perfusing stem cells into the heart to promote repair after a heart attack is safe and improves outcomes such as cardiac arrhythmias, pulmonary function, left ventricular function and overall symptoms, according to a study in the Dec. 8 issue of the Journal of the American College of Cardiology.

LATEST ARTICLES

Roflumilast: A new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease

Roflumilast is a novel, orally active phosphodiesterase 4 inhibitor currently under review by FDA for the treatment of patients with moderate-to-severe COPD.

Statins and cancer: Discovering their role in treating gynecologic cancers

HMG-CoA reductase inhibitors, commonly referred to as statins, have gained popularity for their ability to effectively lower cholesterol levels in patients with CV disease, but new roles for statins may be on the horizon.

Coronary heart disease: Primary and secondary prevention (CE)

Heart disease is the leading cause of death in the United States. Prevention is crucial to improving morbidity and mortality for many Americans. Risk factors can be targeted by pharmacologic and nonpharmacologic means.

Easier pediatric blood pressure screening

Dr. Andrew Schuman recently sat down with Dr. David Kaelber to discuss the implications of his vastly simplified screening tool for pediatric hypertension.

P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight

The P&T committee is positioned to provide knowledge, strategies to improve treatment of patients with cardiometabolic disorders.